Assembly Biosciences Inc <ASMB.O>: Mizuho raises target price to $53 from $45
ASMB•Related News
LPL Financial Holdings Inc. <LPLA.O>: Truist Securities initiates coverage with hold rating; price target $389
LPLA•
Morning News Call - U.S., September 1
SPY•
RedHill Biopharma buys commercialization rights to Ferring’s Rebyota, Clenpiq for $12 million upfront
RDHL•
Moderna to present at Morgan Stanley Global Healthcare Conference
MRNA•
Medtronic boosts fiscal 2027 forecasts on heart device demand
MDT•